Formula 303

Valerian Root, Passiflora, Magnesium Carbonate


Dee Cee Laboratories
Human Otc Drug
NDC 52301-303
Formula 303 also known as Valerian Root, Passiflora, Magnesium Carbonate is a human otc drug labeled by 'Dee Cee Laboratories'. National Drug Code (NDC) number for Formula 303 is 52301-303. This drug is available in dosage form of Tablet. The names of the active, medicinal ingredients in Formula 303 drug includes Magnesium Carbonate - 1 [hp_X]/1 Passiflora Incarnata Flower - 3 [hp_X]/1 Valerian - 6 [hp_X]/1 . The currest status of Formula 303 drug is Active.

Drug Information:

Drug NDC: 52301-303
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Formula 303
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Valerian Root, Passiflora, Magnesium Carbonate
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Dee Cee Laboratories
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Tablet
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:MAGNESIUM CARBONATE - 1 [hp_X]/1
PASSIFLORA INCARNATA FLOWER - 3 [hp_X]/1
VALERIAN - 6 [hp_X]/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 19 Sep, 1990
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 05 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Dee Cee Laboratories
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:0E53J927NA
K8F3G29S6Z
JWF5YAW3QW
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
52301-303-12120 TABLET in 1 BOTTLE (52301-303-12)23 Jun, 2017N/ANo
52301-303-2112 TABLET in 1 BAG (52301-303-21)23 Jun, 2017N/AYes
52301-303-25250 TABLET in 1 BOTTLE (52301-303-25)19 Sep, 1990N/ANo
52301-303-30300 TABLET in 1 BOTTLE (52301-303-30)23 Jun, 2017N/ANo
52301-303-4545 TABLET in 1 BOTTLE (52301-303-45)19 Sep, 1990N/ANo
52301-303-6060 TABLET in 1 BOTTLE (52301-303-60)23 Jun, 2017N/ANo
52301-303-9090 TABLET in 1 BOTTLE (52301-303-90)19 Sep, 1990N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Natural relief for muscle spasm, tension, and stress

Product Elements:

Formula 303 valerian root, passiflora, magnesium carbonate passiflora incarnata flower passiflora incarnata flower magnesium carbonate carbonate ion valerian valerian sodium starch glycolate type a potato maltodextrin lactose monohydrate stearic acid silicon dioxide brown with dark brown speckles 36

Indications and Usage:

Muscle spasm: as a muscle relaxant, two tablets every three hours until relief is obtained. then two tablets with each meal and two and bedtime. tension and stress: as a relaxant, two tablets with each meal and two at bedtime.

Warnings:

Warning: if you are pregnant or nursing a baby, seek the advice of a healthcare professional before using this product.

Dosage and Administration:

Directions: adults and children 12 years of age and older, take as directed or as directed by your doctor. do not exceed 12 tablets in a 24 hour period. muscle spasm: as a muscle relaxant, two tablets every three hours until relief is obtained. then two tablets with each meal and two at bedtime. tension and stress: as a relaxant, two tablets with each meal and two at bedtime.

Package Label Principal Display Panel:

Main panel


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.